Drug recall
Tamoxifen Citrate Tablets, USP, 10 mg, 180 count bottle, Rx only, Manufactured In Israel By: Teva…
FDA recall event 56835 · Class II · Teva Pharmaceuticals USA, Inc.
Key facts
| Event ID | 56835 |
|---|---|
| Recall numbers | D-082-2011 |
| Recalling firm | Teva Pharmaceuticals USA, Inc. |
| Product type | Drugs |
| Products | Tamoxifen Citrate Tablets, USP, 10 mg, 180 count bottle, Rx only, Manufactured In Israel By: Teva Pharmaceutical Ind. Ltd, Jerusalem, 91010, Israel, Manufactured For: Teva Pharmaceuticals USA… |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Tablet Thickness: After receiving a complaint of a thick tablet, the firm determined that some tablets may not meet weight requirements |
| Initiation date | Sep 22, 2010 |
| Termination date | Aug 31, 2012 |
| City | Sellersville |
| State | PA |
| Country | United States |
| FEI number | 2517175 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports